{
    "clinical_study": {
        "@rank": "24907", 
        "arm_group": [
            {
                "arm_group_label": "single stem cell transplant, 3-year lenalidomide maintenance", 
                "arm_group_type": "Active Comparator", 
                "description": "Arm A"
            }, 
            {
                "arm_group_label": "tandem autologous transplant, lenalidomide maintenance", 
                "arm_group_type": "Experimental", 
                "description": "Arm B"
            }, 
            {
                "arm_group_label": "allogeneic stem cell transplant, lenalidomide maintenance", 
                "arm_group_type": "Active Comparator", 
                "description": "Arm C"
            }, 
            {
                "arm_group_label": "tandem autologous transplant", 
                "arm_group_type": "Experimental", 
                "description": "Arm D"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators propose this study utilizing Lenalidomide, Adriamycin, Dexamethasone\n      (RAD) as comparator arm for Lenalidomide, Bortezomib, Dexamethasone (VRD) with the latter\n      being considered a novel \"standard\" as an induction protocol, since response in general\n      occurs early after starting treatment we decided to choose three cycles of either induction\n      regimen.\n\n      Together with the \"novel compounds\", tandem high-dose melphalan is still the standard of\n      care; it seems desirable to re-address the question of the number of transplant (single vs.\n      double high-dose melphalan) procedures required in the context of triplet-induction\n      protocols utilizing at least one of the novel compounds.\n\n      Thus, the question to be asked in the current protocol is whether immediate lenalidomide\n      maintenance (i.e. following one cycle of high-dose therapy) as an investigational agent will\n      result in identical progression free survival (PFS) when compared to tandem high-dose\n      melphalan with deferred maintenance therapy.\n\n      Despite induction with novel compounds, approximately 25 - 40% of patients will be in less\n      than very good partial response. Very recently, achievement of less than VGPR was confirmed\n      to negatively impact on both PFS as well as overall survival (OS). Therefore, allogeneic\n      stem cell transplantation is considered the standard of care in patients with suboptimal\n      response to a first autograft.\n\n      In the current protocol, the standard for favourable responders (tandem-autologous\n      transplant) is combined with 3 years of lenalidomide maintenance. This approach will be\n      investigated for patients with less than VGPR following a first autotransplant and compared\n      to the current standard of intensification in poor responders (allogeneic transplantation)."
        }, 
        "brief_title": "Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance", 
        "completion_date": {
            "#text": "May 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Previously Untreated Symptomatic Multiple Myeloma", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Myeloma", 
                "Neoplasms, Plasma Cell"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Understand and voluntarily sign an informed consent form\n\n          -  Patients willing and able to undergo autologous and allogeneic transplantation\n\n          -  no previous systemic therapy for the treatment of multiple myeloma (dexamethasone at\n             a cumulative dose of 320 mg; plasmapheresis/dialysis without concomitant\n             chemotherapy, local irradiation of bone lesions; and surgical intervention is\n             accepted as pretreatment)\n\n          -  Newly diagnosed multiple myeloma according to common diagnostic criteria including\n             presence of CRAB and measurable disease parameters\n\n          -  Cardiac ejection fraction (LVEF) of at least 50%\n\n          -  Corrected DLCO of at least 50% ; alternatively pO2 [art.] of at least 70mmHg\n\n          -  Karnofsky performance status of greater or equal to 50%\n\n          -  adequate bone marrow function\n\n          -  adequate serum chemistry values\n\n          -  Use of adequate contraception for female subjects with childbearing potential and\n             male subjects\n\n          -  Bone marrow sample available for analysis of molecular cytogenetics\n\n          -  Able to administer low molecular-weight heparin as a prophylactic anticoagulation\n             therapy for the first three months(applicable for subjects randomized to RAD) and\n             able to administer ASS 100 mg/d (applicable for subjects randomized to VRD)\n\n        Exclusion Criteria:\n\n          -  Any serious medical condition, laboratory abnormality, or psychiatric illness that\n             would prevent the subject from signing the informed consent form\n\n          -  Pregnant or lactating females\n\n          -  Any condition, including the presence of laboratory abnormalities, which places the\n             subject at unacceptable risk\n\n          -  History of myocardial infarction; NYHA Class III or IV heart failure, uncontrolled\n             angina, severe uncontrolled ventricular arrhythmias; concomitant pericarditis or\n             peri-/myocarditis\n\n          -  Use of any other experimental drug or therapy within 28 days of baseline\n\n          -  Greater or equal to Grade 2 peripheral neuropathy on clinical examination within 14\n             days before enrollment\n\n          -  Known intolerance of boron\n\n          -  Hypersensitivity to acyclovir or similar anti-viral drug\n\n          -  Prior malignancy except adequately treated basal cell or squamous cell skin cancer,\n             in situ cervical, breast or prostate cancer\n\n          -  HIV positive, active hepatitis B, C or D viral infection, known CMV\n             reactivation/active infection, EBV reactivation/active infection or treponema\n             pallidum infection\n\n          -  Uncontrolled diabetes mellitus\n\n          -  Non-secretory MM\n\n          -  Clinically relevant active infection or serious co-morbid medical conditions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "406", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 27, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01685814", 
            "org_study_id": "DSMM XIV", 
            "secondary_id": "2009-016616-21"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "single stem cell transplant, 3-year lenalidomide maintenance", 
                    "tandem autologous transplant, lenalidomide maintenance", 
                    "allogeneic stem cell transplant, lenalidomide maintenance", 
                    "tandem autologous transplant"
                ], 
                "description": "Induction: two versus one novel drug maintenance: lenalidomide as a maintenance therapy", 
                "intervention_name": "Lenalidomide, Bortezomib", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "single stem cell transplant, 3-year lenalidomide maintenance", 
                    "tandem autologous transplant, lenalidomide maintenance", 
                    "allogeneic stem cell transplant, lenalidomide maintenance", 
                    "tandem autologous transplant"
                ], 
                "intervention_name": "autologous stem cell transplant", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "allogeneic stem cell transplant, lenalidomide maintenance", 
                "intervention_name": "allogeneic stem cell transplant", 
                "intervention_type": "Biological"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Dexamethasone acetate", 
                "Dexamethasone", 
                "Dexamethasone 21-phosphate", 
                "Bortezomib", 
                "Lenalidomide", 
                "Doxorubicin", 
                "Thalidomide", 
                "BB 1101"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "multiple myeloma", 
            "autologous stem cell transplant", 
            "allogeneic stem cell transplant", 
            "lenalidomide", 
            "bortezomib"
        ], 
        "lastchanged_date": "September 11, 2012", 
        "location": [
            {
                "contact": {
                    "last_name": "Tim Br\u00fcmmendorf, MD", 
                    "phone": "(0049) 241/80-89805"
                }, 
                "facility": {
                    "address": {
                        "city": "Aachen", 
                        "country": "Germany", 
                        "zip": "52074"
                    }, 
                    "name": "Universit\u00e4tsklinikum Aachen, Med. Klinik IV, H\u00e4matologie u. Onkologie"
                }, 
                "investigator": {
                    "last_name": "Tim Br\u00fcmmendorf, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christian Straka, MD", 
                    "phone": "(0049)-8151-17817"
                }, 
                "facility": {
                    "address": {
                        "city": "Berg", 
                        "country": "Germany", 
                        "zip": "82335"
                    }, 
                    "name": "Sch\u00f6n Klinik Starnberger See, H\u00e4matologie und Onkologie"
                }, 
                "investigator": {
                    "last_name": "Christian Straka, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Isrid Sturm, MD", 
                    "phone": "(0049) 30-450-553302"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }, 
                    "name": "Campus Virchow-Klinikum Charite\u00b4, Charite\u00b4- Centrum 14, Med. Klinik H\u00e4matologie u. Onkologie"
                }, 
                "investigator": {
                    "last_name": "Isrid Sturm, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Bernd Hertenstein, MD", 
                    "phone": "(0049)-421-4975240"
                }, 
                "facility": {
                    "address": {
                        "city": "Bremen", 
                        "country": "Germany", 
                        "zip": "28177"
                    }, 
                    "name": "Klinikum Bremen-Mitte gGmbH, Klinik f\u00fcr Innere Medizin I"
                }, 
                "investigator": {
                    "last_name": "Bernd Hertenstein, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christoph R\u00f6llig, MD", 
                    "phone": "(0049)-351-45813775"
                }, 
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany", 
                        "zip": "01307"
                    }, 
                    "name": "Universit\u00e4tsklinikum Carl Gustav Carus an der TU Dresden, Medizinische Klinik und Poliklinik I"
                }, 
                "investigator": {
                    "last_name": "Christoph R\u00f6llig, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Wolf R\u00f6sler, MD", 
                    "phone": "(0049) 9131-85-35954"
                }, 
                "facility": {
                    "address": {
                        "city": "Erlangen", 
                        "country": "Germany", 
                        "zip": "91054"
                    }, 
                    "name": "Universit\u00e4tsklinikum Erlangen, Medizinische Klinik 5"
                }, 
                "investigator": {
                    "last_name": "Wolf R\u00f6sler, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nadezda Basara, MD", 
                    "phone": "(0049) 461/816-2512"
                }, 
                "facility": {
                    "address": {
                        "city": "Flensburg", 
                        "country": "Germany", 
                        "zip": "24939"
                    }, 
                    "name": "Malteser Krankenhaus St. Franziskus-Hospital, medizinische Klinik I"
                }, 
                "investigator": {
                    "last_name": "Nadezda Basara, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ivana von Metzler, MD", 
                    "phone": "(0049) 69 / 6301-0"
                }, 
                "facility": {
                    "address": {
                        "city": "Frankfurt am Main", 
                        "country": "Germany", 
                        "zip": "60596"
                    }, 
                    "name": "Klinikum der Johann Woflgang Goethe Universit\u00e4t, Frankfurt am Mai"
                }, 
                "investigator": {
                    "last_name": "Ivana von Metzler, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michael Kiehl, MD", 
                    "phone": "(0049) 335-548-4600"
                }, 
                "facility": {
                    "address": {
                        "city": "Frankfurt/Oder", 
                        "country": "Germany", 
                        "zip": "15236"
                    }, 
                    "name": "Klinikum Frankfurt (Oder) GmbH Medizinische Klinik I"
                }, 
                "investigator": {
                    "last_name": "Michael Kiehl, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Monika Engelhardt, MD", 
                    "phone": "(0049)-761-27032460"
                }, 
                "facility": {
                    "address": {
                        "city": "Freiburg", 
                        "country": "Germany", 
                        "zip": "79106"
                    }, 
                    "name": "Universit\u00e4tsklinikum Freiburg, Abteilung f\u00fcr Innere Medizin I"
                }, 
                "investigator": {
                    "last_name": "Monika Engelhardt, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gotfried D\u00f6lken, MD", 
                    "phone": "(0049)-3834-866698"
                }, 
                "facility": {
                    "address": {
                        "city": "Greifswald", 
                        "country": "Germany", 
                        "zip": "174751"
                    }, 
                    "name": "Universit\u00e4tmedizin Greifswald, Klinik und Poliklinik f\u00fcr Innere Medizin C"
                }, 
                "investigator": {
                    "last_name": "Gottfried D\u00f6lken, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Heinz D\u00fcrk, MD", 
                    "phone": "(0049)-2381-182251"
                }, 
                "facility": {
                    "address": {
                        "city": "Hamm", 
                        "country": "Germany", 
                        "zip": "59071"
                    }, 
                    "name": "St. Marien-Hospital gem. GmbHKna"
                }, 
                "investigator": {
                    "last_name": "Heinz D\u00fcrk, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michael Preundschuh, MD", 
                    "phone": "(0049)-6841-162-3002"
                }, 
                "facility": {
                    "address": {
                        "city": "Homburg/Saar", 
                        "country": "Germany", 
                        "zip": "66421"
                    }, 
                    "name": "Universit\u00e4tsklinikum des Saarlandes Innere Medizin I"
                }, 
                "investigator": {
                    "last_name": "Michael Preundschuh, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Lars-Olof M\u00fcgge, MD", 
                    "phone": "(0049) 3641/932-4570"
                }, 
                "facility": {
                    "address": {
                        "city": "Jena", 
                        "country": "Germany", 
                        "zip": "07747"
                    }, 
                    "name": "Klinikum der Friedrich-Schiller-Universit\u00e4t Jena, Klinikum f\u00fcr Innrere Medizin II"
                }, 
                "investigator": {
                    "last_name": "Lars-Olof M\u00fcgge, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mark Ringhoffer, MD", 
                    "phone": "(0049) 721/974-3001"
                }, 
                "facility": {
                    "address": {
                        "city": "Karlsruhe", 
                        "country": "Germany", 
                        "zip": "76133"
                    }, 
                    "name": "St\u00e4dtisches Klinikum Karlsruhe Medizinische Klinik III, Abt. H\u00e4matologie u. Onkologie"
                }, 
                "investigator": {
                    "last_name": "Mark Ringhoffer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michael Kneba", 
                    "phone": "(0049) 431/1697-1201"
                }, 
                "facility": {
                    "address": {
                        "city": "Kiel", 
                        "country": "Germany", 
                        "zip": "24116"
                    }, 
                    "name": "Universit\u00e4tsklinikum Schleswig-Holstein, Medizinische Klinik und Poliklinik II im st\u00e4dtischen Krankenhaus Kiel"
                }, 
                "investigator": {
                    "last_name": "Michael Kneba, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Martin Gramatzki, MD", 
                    "phone": "(0049)-431-597-5802"
                }, 
                "facility": {
                    "address": {
                        "city": "Kiel", 
                        "country": "Germany", 
                        "zip": "24105"
                    }, 
                    "name": "Universit\u00e4tsklinikum Schleswig-Holstein Campus Kiel, II. Med. Poliklinik"
                }, 
                "investigator": {
                    "last_name": "Martin Gramatzki, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ralph Naumann, MD", 
                    "phone": "(0049)-261-1377558"
                }, 
                "facility": {
                    "address": {
                        "city": "Koblenz", 
                        "country": "Germany", 
                        "zip": "56068"
                    }, 
                    "name": "Stiftungsklinikum Mittelrhein GmbH, Klinik f\u00fcr Innere Medizin"
                }, 
                "investigator": {
                    "last_name": "Ralph Naumann, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Harald Biersack, MD", 
                    "phone": "(0049) 451/500-0"
                }, 
                "facility": {
                    "address": {
                        "city": "L\u00fcbeck", 
                        "country": "Germany", 
                        "zip": "23538"
                    }, 
                    "name": "Universit\u00e4tsklinikum Schleswig-Holstein, Campus L\u00fcbeck, Medizinische Klinik I"
                }, 
                "investigator": {
                    "last_name": "Harry Biersack, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Stefan Klein, MD", 
                    "phone": "(0049) 621-383-4116"
                }, 
                "facility": {
                    "address": {
                        "city": "Mannheim", 
                        "country": "Germany", 
                        "zip": "68167"
                    }, 
                    "name": "Universit\u00e4tsmedizin Mannheim medizinische Klinik III"
                }, 
                "investigator": {
                    "last_name": "Stefan Klein, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Florian Bassermann, MD", 
                    "phone": "(0049) 89/4140-5038"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany", 
                        "zip": "81675"
                    }, 
                    "name": "III. Med. Klinik und Poliklinik, Klinikum rechts der Isar der TU M\u00fcnchen"
                }, 
                "investigator": {
                    "last_name": "Florian Bassermann, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Clemens-Martin Wendtner, MD", 
                    "phone": "(0049)-3068-2228"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany", 
                        "zip": "80804"
                    }, 
                    "name": "Klinikum Schwabing"
                }, 
                "investigator": {
                    "last_name": "Clemens-Martin Wendtner, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Helmut Ostermann, MD", 
                    "phone": "(0049)-89-7095-6038"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany", 
                        "zip": "81366"
                    }, 
                    "name": "Klinikum der Universit\u00e4t M\u00fcnchen-Gro\u00dfhadern"
                }, 
                "investigator": {
                    "last_name": "Helmut Ostermann, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Martin Kropff, MD", 
                    "phone": "(0049)-251-8347590"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnster", 
                        "country": "Germany", 
                        "zip": "48149"
                    }, 
                    "name": "Universit\u00e4tsklinikum M\u00fcnster, Medizinische Klinik u. Poliklinik A"
                }, 
                "investigator": {
                    "last_name": "Martin Kropff, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Kerstin Sch\u00e4fer-Eckart, MD", 
                    "phone": "(0049)-911-398-3650"
                }, 
                "facility": {
                    "address": {
                        "city": "N\u00fcrnberg", 
                        "country": "Germany", 
                        "zip": "90419"
                    }, 
                    "name": "Klinikum N\u00fcrnberg Nord, 5. Medizinische LKinik, Onkologie/H\u00e4matologie"
                }, 
                "investigator": {
                    "last_name": "Kerstin Sch\u00e4fer-Eckart, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Bernd Metzner, MD", 
                    "phone": "(0049)-441-403-2614"
                }, 
                "facility": {
                    "address": {
                        "city": "Oldenburg", 
                        "country": "Germany", 
                        "zip": "26133"
                    }, 
                    "name": "Klinikum Oldenburg GmbH, Klinik f\u00fcr Innere Medizin II"
                }, 
                "investigator": {
                    "last_name": "Bernd Metzner, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Georg Maschmeyer, MD", 
                    "phone": "(0049) 0331/241-0"
                }, 
                "facility": {
                    "address": {
                        "city": "Potsdam", 
                        "country": "Germany", 
                        "zip": "14467"
                    }, 
                    "name": "Klinikum Ernst von Bergmann, Klinik f\u00fcr H\u00e4matologie, Onkologie"
                }, 
                "investigator": {
                    "last_name": "Georg Maschmeyer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Albrecht Reichle", 
                    "phone": "(0049)-941-944-5541"
                }, 
                "facility": {
                    "address": {
                        "city": "Regensburg", 
                        "country": "Germany", 
                        "zip": "93053"
                    }, 
                    "name": "Uniklinikum Regensburg, Abteilung f\u00fcr H\u00e4matologie und internistische Onkologie"
                }, 
                "investigator": {
                    "last_name": "Albrecht Reichle, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Hans-Guenther Mergenthaler, MD", 
                    "phone": "(0049)-711-278-35601"
                }, 
                "facility": {
                    "address": {
                        "city": "Stuttgart", 
                        "country": "Germany", 
                        "zip": "70174"
                    }, 
                    "name": "Klinikum Stuttgart, Katharinenhospital"
                }, 
                "investigator": {
                    "last_name": "Hans-G\u00fcnther Mergenthaler, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Martin Kaufmann, MD", 
                    "phone": "(0049) 711/8101-0"
                }, 
                "facility": {
                    "address": {
                        "city": "Stuttgart", 
                        "country": "Germany", 
                        "zip": "70376"
                    }, 
                    "name": "Robert-Bosch-Krankenhaus, Abt. H\u00e4matologie, Onkologie u. Palliativmedizin"
                }, 
                "investigator": {
                    "last_name": "Martin Kaufmann, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christian Langer, MD", 
                    "phone": "(00749) 31-500-45743"
                }, 
                "facility": {
                    "address": {
                        "city": "Ulm", 
                        "country": "Germany", 
                        "zip": "89081"
                    }, 
                    "name": "Universit\u00e4tsklinikum Ulm,Klinik f\u00fcr Innere Medizin III"
                }, 
                "investigator": {
                    "last_name": "Christian Langer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Wolfram Brugger, MD", 
                    "phone": "(0049) 7721/93-4001"
                }, 
                "facility": {
                    "address": {
                        "city": "Villingen-Schwenningen", 
                        "country": "Germany", 
                        "zip": "78048"
                    }, 
                    "name": "Schwarzwald-Baar Klinkum Villingen-Schwennigen GmbH"
                }, 
                "investigator": {
                    "last_name": "Wolfram Brugger, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Norbert Frickhofen, MD", 
                    "phone": "(0049) 611 433018"
                }, 
                "facility": {
                    "address": {
                        "city": "Wiesbaden", 
                        "country": "Germany", 
                        "zip": "65199"
                    }, 
                    "name": "Dr. Horst Schmidt Kliniken, Klinik Innere Medizin III"
                }, 
                "investigator": {
                    "last_name": "Norbert Frickhofen, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Hermann Einsele, MD", 
                    "phone": "(0049)-931-201-40001"
                }, 
                "facility": {
                    "address": {
                        "city": "Wuerzburg", 
                        "country": "Germany", 
                        "zip": "97080"
                    }, 
                    "name": "Universit\u00e4tsklinikum Wuerzburg, Medizinische Klinik II"
                }, 
                "investigator": {
                    "last_name": "Hermann Einsele, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "4", 
        "official_title": "Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance - A Randomized Multicenter Phase III Trial by Deutsche Studiengruppe Multiples Myelom (DSMM XIV", 
        "overall_contact": {
            "email": "dsmm@klinik.uni-wuerzburg.de", 
            "last_name": "Stefan Knop, MD", 
            "phone": "+49-931-201-0"
        }, 
        "overall_official": [
            {
                "affiliation": "Wuerzburg University Hospital", 
                "last_name": "Stefan Knop, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Wuerzburg University Hospital", 
                "last_name": "Hermann Einsele, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "The primary efficacy endpoint for the induction phase is the rate of patients with CR at first restaging", 
                "safety_issue": "No", 
                "time_frame": "within 8 days after end of last induction cycle ((Day 92(RAD); Day 71(VRD))"
            }, 
            {
                "measure": "In the consolidation phase the primary efficacy endpoint for comparison II (response <VGPR after first ASCT) is the PFS rate", 
                "safety_issue": "No", 
                "time_frame": "3 years after the first ASCT, calculated from day 1 of ASCT."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01685814"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "ORR following 3 cycles of induction treatment (VRD vs RAD)", 
                "safety_issue": "No", 
                "time_frame": "within 8 days after end of last induction cycle"
            }, 
            {
                "measure": "CR and ORR at the end of the whole treatment programme", 
                "safety_issue": "No", 
                "time_frame": "at the end of the whole treatment programme (approx. 8 years)"
            }, 
            {
                "measure": "Overall survival (OS)", 
                "safety_issue": "No", 
                "time_frame": "8 years from study entry"
            }, 
            {
                "measure": "Incidence, severity and relationship of SAEs", 
                "safety_issue": "Yes", 
                "time_frame": "30 days post last dosing of study drug"
            }, 
            {
                "measure": "Numbers of hospital stays and hospitalization days", 
                "safety_issue": "No", 
                "time_frame": "within two years from second restaging"
            }
        ], 
        "source": "Wuerzburg University Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "ClinAssess GmbH", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Celgene Corporation", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "Wuerzburg University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}